ONCY
Oncolytics Biotech, Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.98
+0.02 ▲ +2.34%
🌙 3월 13일 7:57 PM ET (한국 3/14 08:57)
$1.00
+0.02 ▲ +1.62%
| Index | - | P/E | - | EPS (ttm) | -0.28 | Insider Own | 2.21% | Shs Outstand | 0.10B | Perf Week | -7.17% |
| Market Cap | 0.11B | Forward P/E | - | EPS next Y | 5.4% | Insider Trans | 20.48% | Shs Float | 0.10B | Perf Month | 15.29% |
| Enterprise Value | 0.10B | PEG | - | EPS next Q | -0.06 | Inst Own | 2.8% | Short Float | 6.78% | Perf Quarter | -0.57% |
| Income | -0.03B | P/S | - | EPS this Y | 9.33% | Inst Trans | -0.02% | Short Ratio | 4.94 | Perf Half Y | -24.89% |
| Sales | 0.00B | P/B | 1230 | EPS next 5Y | 7.12% | ROA | -175.83% | Short Interest | 6.65M | Perf YTD | 12.59% |
| Book/sh | 0 | P/C | 11.92 | EPS past 3/5Y | 8.27% 23.13% | ROE | -745.62% | 52W High | -34.83% ($1.51) | Perf Year | 57.95% |
| Cash/sh | 0.08 | P/FCF | - | Sales past 3/5Y | - | ROIC | -5238.85% | 52W Low | 202.03% ($0.33) | Perf 3Y | -20.65% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -4.93% | Gross Margin | - | Volatility(W/M) | 5.78% 8.95% | Perf 5Y | -67.09% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.08 | Perf 10Y | -64.89% |
| Dividend Ex-Date | - | Quick Ratio | 1.84 | EPS Q/Q | -13.66% | Profit Margin | - | RSI (14) | 46.79 | Recom | 1.33 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.84 | Sales Q/Q | - | SMA20 | -5.32% ($1.04) | Beta | 0.92 | Target Price | $5.5 |
| Payout | - | Debt/Eq | 7.5 | Earnings | 11000000 | SMA50 | -2.46% ($1) | Rel Volume | 0.44 | Prev Close | $0.96 |
| Employees | 28 | LT Debt/Eq | 5 | EPS/Sales Surpr. | -61.39% - | SMA200 | -2.96% ($1.01) | Avg Volume(3M) | 1.35M | Price | $0.98 |
| IPO | 2001/10/5 | Option/Short | No/Yes | Trades | 1677 | Volume | 592,837 | Change | 2.34% |
뉴스 로딩 중...